| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.51 | 9e-37 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.25 | 2e-12 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.2 | 8e-12 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.27 | 4e-10 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.23 | 8e-10 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-09 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-08 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-08 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-08 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-08 |